Biocon Limited
Biocon Limited (BIOCON) is a leading biopharmaceutical company based in India, specializing in the development of innovative therapies for chronic conditions such as diabetes, cancer, and autoimmune diseases. Established in 1978, the company operates across several sectors including biologics, generics, and research services. Core products include biosimilars, insulin formulations, and novel biologics, with a strong emphasis on affordable healthcare solutions.